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Background: The purpose of the present investigation was to compare the bouts of daily physical activity (PA)
determined by three different accelerometer epoch lengths under free-living conditions.
Methods: One hundred thirty-four adults (50 ± 7 years) wore an accelerometer (Lifecorder) for 7 consecutive days
under free-living conditions in order to determine the time spent in physical activity of light intensity (LPA),
moderate intensity (MPA), vigorous intensity (VPA), moderate to vigorous intensity (MVPA), and the total physical
activity (TPA; sum of LPA, MPA and VPA). Additionally, all PA was divided according to the bout durations
(sporadic, >3 min, >5 min, and > 10 min). These indices of PA were analyzed using three different epoch lengths
(4 sec, 20 sec and 60 sec) derived from the accelerometer.
Results: The LPA significantly increased in association with increases in the epoch length (48.7 ± 15.9 to 178.7 ±
62.6 min/day, p < 0.05). The amount of sporadic VPA determined by the shortest epoch length (2.9 ± 5.2 min/day)
was significantly longer than the two remaining epoch lengths (1.1 ± 2.4 to 0.9 ± 2.5 min/day, p < 0.05). The times
of the MVPA bouts lasting longer than 3 minutes determined using the 4-second epoch length (2.6 ± 5.4 to 7.7 ±
10.0 min/day) were significantly shorter than those determined using the other two settings (6.5 ± 10.5 to 13.8 ±
13.8 min/day, p < 0.05). The frequencies of the MVPA bouts lasting longer than 10 minutes determined using the
4-second epoch length (0.2 ± 0.3 bouts/day) were significantly lower than those determined using the other two
settings (0.3 ± 0.4 bouts/day, p < 0.05).
Conclusion: The epoch length setting of the accelerometer affects the estimation of the PA bouts under free-living
conditions in middle-aged to older adults.
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The American College of Sports Medicine and the
American Heart Association recommend that all healthy
adults 18 to 65 years of age engage in moderate-intensity
aerobic (endurance) physical activity (MPA) or vigorous-
intensity aerobic physical activity (VPA) in order to
promote and maintain health [1]. Since several consensus
statements also recommend engaging in moderate to vig-
orous intensity physical activity (MVPA) [2,3], spending a
longer time performing MVPA is widely accepted to be a
goal for a healthy lifestyle. Additionally, moderate-
intensity aerobic activity, which is generally equivalent to a
brisk walk that noticeably accelerates the heart rate, can* Correspondence: ayabemakoto@mac.com
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reproduction in any medium, provided the orcount toward the 30 minute minimum by performing
bouts of activity lasting 10 minutes or more [1].
Strath et al. [4] showed that bouts of PA lasting ≥ 10 min-
utes may constitute a more time-efficient strategy to
decrease body mass index and waist circumference. In
addition, accumulating MVPA in shorter bouts might be a
beneficial starting point for individuals to increase their
PA levels and decrease their body mass index and waist
circumference. Furthermore, sustained volitional activity
(i.e., ≥ 10 min in duration) might play an important role for
the long-term maintenance of weight loss [5]. These find-
ings indicate that participating in MVPA lasting > 10 min
might be more beneficial than accumulating sporadic
MVPA.
However, with regard to bouts of MVPA lasting > 10 min-
utes, no consistent definition has been used to evaluateLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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recording intervals seems to be the de facto bout definition
[6]. Accelerometers function by integrating a filtered digi-
tized acceleration signal over a user-specified time interval,
commonly referred to as an epoch [7]. The usual acceler-
ometer stored magnitude of accelerations at fixed record-
ing intervals (1 sec, 4 sec, 15 sec, or 60 sec or longer) is
called an “epoch” [8]. At the end of each epoch, the some
index of physical activity is calculated; this process is
repeated until data collection is completed [8,9]. Recent
studies examined the appropriate epoch length to estimate
the sporadic MVPA [7,8,10], and the use of a shorter time
sampling interval might reduce the misclassification errors
of PA estimates [8]. However, there have been no studies
that have directly compared the bouts of PA determined
using different epoch lengths under free-living conditions.
Since most walking bouts last 30 sec or less [11,12], we
hypothesized that a shorter epoch length may be more
suitable to reflect the “real” bout duration under free-
living conditions.
Therefore, the purpose of the present investigation was
to examine the effects of the epoch length lasting from
4 seconds to 1 minute on the evaluation of bouts of PA
lasting longer than 3, 5 and 10 minutes under free-living
conditions in middle- to older-aged adults.Methods
Subjects
One hundred and thirty-four adults, aged from 32 to
72 yr., participated in the present investigation. All
volunteers were recruited from Fukuoka city (Fukuoka,
Japan) by the newspaper and web site. All volunteers liv-
ing independently and were free of debilitating chronic
diseases. Furthermore, none of the participants habit-
ually participated in any sports activities. The character-
istics of the participants are shown in Table 1 (Table 1).
After an explanation of the study requirements, each
subject read and signed a consent form. The ethics com-
mittee of Fukuoka University approved all procedures
used in the present investigation. All procedures relatedTable 1 Characteristics of participants
All Female Male
N 134 42 92
Age (years) 50 ± 7 50 ± 7 50 ± 8
Height (cm) 165.0 ± 8.1 156.2 ± 4.9 169.1 ± 5.8*
Body weight (kg) 66.7 ± 12.4 54.7 ± 8.4 72.3 ± 9.8*
Body mass index (kg/m2) 23.3 ± 6.9 28.5 ± 6.9 21.0 ± 5.5*
Waist circumference 88.2 ± 8.8 84.3 ± 9.7 90.0 ± 7.8*
Data are expressed as the means with the standard deviation (mean ± SD).
*Significantly different between males and females (p < 0.01).to the measurements were performed between March
and April.
Physical activity assessments
During the course of the present investigation, all parti-
cipants wore a pedometer with a uni-axial accelerometer
(Lifecorder Ex 4-sec version, Kenz, Nagoya, Japan; LC)
under free-living conditions. The LC is a small and light-
weight (60 mm × 46 mm × 26 mm, 42 g) device that is
equipped with a uni-axial piezo-electronic accelerometer
that samples vertical acceleration ranging between
0.06 G and 1.94 G at 32 Hz. Based on the magnitude
and frequency of accelerations, the LC determines the
level of movement intensity every 4 seconds on a scale
of 1 (minimal intensity of movement) to 9 (maximal in-
tensity of movement). As shown in a previous investiga-
tion [9], the intensity levels closely approximated the
metabolic equivalents (METs) of the activities being per-
formed. Previous investigations have demonstrated that
the LC is suitable for research purposes [9,13,14]. The
LC has the potential limitation, similar to other types of
activity monitors, in that they too often remain vulner-
able to problems from external vibrations and unmeas-
ured sources of energy expenditure such as hill climbing
and isometric activity in daily life [15]. After reading the
instructions regarding the general care of these activity
monitors, the participants wore the LC for 10 days con-
tinuously, except while sleeping or bathing. We used
seven continuous days (the 4th day to the 10th day, five
weekdays and two weekend days) for data the analysis
because the 1st to the 10th days included non-wearing
time and the 2nd day was used to familiarize the sub-
jects with the LC. All subjects documented when they
removed the LC die for personal reasons. The LC was
placed on the left anterior mid-line of the thigh on the
waist band of the participant’s clothing. The present in-
vestigation placed the LC on the left side in order to
prevent the LC from being dropped while the subjects
inserted or removed their belts. The LC was sealed, so
that the participants could not gain access to the PA
measurements during the experimental period. After the
data collection period was completed, the participants
returned the LC by mail to the investigators so that the
stored data could be uploaded to a personal computer
for the analysis. To be included in the analysis, each par-
ticipant had to have at least seven days of sufficiently
wearing the device (>10 hours) [7].
Accelerometer’s data analysis
All accelerometer’s out puts were averaged over 7 days,
and weekly values were defined as individuals represented.
Since the present investigation was focused on the acceler-
ometer’s algorithms, the inter individual variability, such
as the day-to-day variability or hourly variability, were not
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[8,14]. In the present investigation, the epoch length was
also set at 20 sec and 60 sec, in addition to the usual 4 sec
setting. The reasons why we chose these three epoch
lengths are as follows: first, the 4 sec and 60 sec epoch
lengths were used in previous studies [6,16,17]. Addition-
ally, as the LC detects the intensity of PA every 4 sec, the
epoch length had to be selected from a multiple of 4 sec,
and the epoch length must be a common divisor of the
bout duration (3 min, 5 min and 10 min). Therefore, we
chose 20 sec as the third epoch length.
The time spent in light intensity PA (LPA), moderate in-
tensity PA (MPA), vigorous intensity PA (VPA), and mod-
erate + vigorous intensity PA (MVPA) was determined.
Furthermore, the sum of the time for LPA, MPA, and
VPA was defined as the total PA (TPA). Thereafter, based
on the time series data of the three epoch lengths, the
TPA and MVPA were divided according to the bout dura-
tions (Sporadic, < 3 min, < 5 min, and < 10 min, respect-
ively). We defined a “bout” as PA that was maintained
completely at an intensity level of 1 or higher for at least
3 minutes, 5 minutes or 10 minutes (TPA3, TPA5, TPA10,
and TPA3, TPA5, TPA10, respectively). Similarly, the daily
time spent for the MVPA lasting at least 3 minutes, 5 min-
utes and 10 minutes were assessed (MVPA3, MVPA5, and
MVPA10, respectively). The reason for using these dura-
tions was as follows: First, only the 3 min bouts of PA had
a significant impact on the post-prandial blood lipids andFigure 1 Accelerometer outputs as determined using three different
14:30 in one of the participants. The upper, middle and lower illustrations ind
60 seconds, respectively. For the epoch length of 4 seconds, no PA bouts last
one PA bout lasting > 10 minutes was detected (14:03 to 14:15). For the epoc
detected (14:03 to 14:15).metabolic syndrome in previous studies [16,18,19]. Fur-
thermore, the bouts of PA lasting longer than 5 min com-
prised just 0.14 percent of all walking bouts under free-
living conditions [11,12]. Finally, the PA bouts lasting
longer than 10 min have been widely recommended by
consensus statements [1] (Figure 1).
Statistics
The data were expressed as the means with standard
deviations. The potential gender-related differences in
the obtained data were analyzed by the unpaired t-test.
A one-way ANOVA and Scheffe’s test were used to com-
pare the PA levels for the 3 different epoch lengths. The
magnitude of the differences between the time and fre-
quency of PA for the 4 sec epoch length compared to
those of the other two epoch lengths was analyzed by
paired t-tests. Statistical significance was set at P < 0.05.
All statistical analyses were performed using the Stat-
View software program (version 5.0.1, SAS Institute,
Cary, NC, USA) (Figure 2).
Results
The height, body weight, body mass index, and waist cir-
cumference were significantly different between males
and females (p < 0.01, Table 1). As none of the acceler-
ometer outputs significantly differed between genders,
the PA data are shown as the combined results for males
and females (Tables 2 and 3). Table 2 shows the timeepoch lengths. Each illustration shows the MET values from 14:00 to
icate the MET values determined by the epoch lengths of 4, 20 and
ing > 10 minutes were detected. For the epoch length of 20 seconds,
h length of 60 seconds, one MVPA bout lasting > 10 minutes was
Figure 2 Differences in the time and frequency of physical activity bouts compared with those determined using a 4 sec epoch length.
The Y-axis shows the differences between the time or the frequency spent on the physical activity bout determined by the 4 sec epoch length
and that by the 20 sec or 60 sec epoch length, respectively. TPA3, TPA5, TPA10; total physical activity lasting longer than 3 min, 5 min and
10 min. MVPA3, MVPA5, MVPA10; moderate to vigorous intensity physical activity lasting longer than 3 min, 5 min and 10 min.
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ent accelerometer epoch lengths. The LPA significantly
increased with the increase in epoch length (p < 0.05).
The amount of sporadic VPA determined by the shortest
epoch length (4 sec) was significantly longer compared
with the two remaining epoch lengths (p < 0.05). Table 3
shows the time and frequency for the PA bouts as deter-
mined using the three different accelerometer epoch
lengths. Regardless of the intensities and bout durations,
the frequency and the time for the PA bouts determined
using the 4 sec epoch length were significantly shorter
compared with the other two settings (p < 0.05). Add-
itionally, the frequency and the time for TPA determined
using the 20 sec epoch length were significantly smaller
compared with that determined using the 60 sec epoch
length (p < 0.05).Table 2 Accelerometer’s epoch length and the time spent
in sporadic physical activity
Epoch length
4 sec 20 sec 60 sec
LPA (min/day) 48.7 ± 15.9 104.2 ± 36.1** 178.7 ± 62.6**, ‡
MPA (min/day) 30.0 ± 14.9 33.2 ± 16.2 28.5 ± 15.9*,†
VPA (min/day) 2.9 ± 5.2 1.1 ± 2.4** 0.9 ± 2.5**
MVPA (min/day) 32.9 ± 16.5 34.3 ± 17.1 29.4 ± 16.9*,†
Data are expressed as the means with the standard deviation (mean ± SD).
LPA; light intensity physical activity, MPA; moderate intensity physical activity,
VPA; vigorous intensity physical activity, MVPA; moderate to vigorous intensity
physical activity.
*, **Significantly different compared with 4 sec (*p < 0.05, **p < 0.01). †,
‡Significantly different compared with 20 sec (†p < 0.05, ‡p < 0.01).Figure 2 shows the differences in the times and fre-
quencies of the bouts of TPA and MVPA between those
determined using the 4-second epoch length and those
determined using the 20- and 60-second epoch lengths.
The magnitudes of the differences in the times and
frequencies of the bouts of TPA determined using the
60-second epoch length were significantly larger than
those determined using the 20-second epoch length
(p <0.001). In contrast, the magnitudes of the differences in
the times and frequencies of the bouts of MVPA did not
differ significantly, except for the time of the MVPA3M.Discussion
The present investigation is, to the best of our knowledge,
the first study to examine the role of an accelerometer’s
epoch length (4 sec, 20 sec and 60 sec) in the evaluation
of PA bouts with regard to accelerometer-based PA assess-
ment in middle- to older-aged individuals. Main finding of
the present investigation is that, regardless of the intensity
and bout duration categories, the frequency and time for
the PA bouts were significantly lower when the shortest
epoch length (4 sec) was used compared with the longer
epoch lengths (20 sec and 60 sec). Furthermore, when the
analysis was limited to the TPA, the frequency and time
for the PA bouts were significantly lower as the epoch
length increased. Although previous investigation exam-
ined the epoch length on the “sporadic MVPA estimation”
[7,8,10], the present investigation firstly showed that the
epoch length affects the “MVPA bouts estimation”. These
Table 3 Frequency and time in bouts of physical activity by 3 different accelerometer’s epoch lengths
Epoch length
4 sec 20 sec 60 sec
Frequency (bouts/day) TPA3 3.3 ± 1.8 5.1 ± 2.0** 9.0 ± 3.3**,‡
TPA5 1.5 ± 1.1 2.7 ± 1.4** 5.6 ± 2.1**, ‡
TPA10 0.4 ± 0.5 0.8 ± 0.8** 2.2 ± 1.1**, ‡
MVPA3 1.1 ± 1.3 1.8 ± 1.3** 1.2 ± 0.9**, ‡
MVPA5 0.5 ± 0.8 0.9 ± 0.8** 0.7 ± 0.7**
MVPA10 0.2 ± 0.3 0.3 ± 0.4** 0.3 ± 0.4**
Time (min/day) TPA3 22.0 ± 15.1 41.3 ± 21.6** 101.8 ± 37.6**, ‡
TPA5 14.8 ± 13.2 30.0 ± 20.3** 80.2 ± 33.2**, ‡
TPA10 6.9 ± 9.9 15.9 ± 17.0** 47.7 ± 27.8**, ‡
MVPA3 7.7 ± 10.0 14.3 ± 12.8** 13.8 ± 13.8**
MVPA5 5.2 ± 8.1 10.3 ± 11.2** 10.6 ± 12.8**
MVPA10 2.6 ± 5.4 5.4 ± 8.8** 6.5 ± 10.5**
Data are expressed as the means with the standard deviation (mean ± SD). TPA3, TPA5, and TPA10; Bouts of physical activity lasting longer than 3 min, 5 min and
10 min. MVPA3, MVPA5, and MVPA10; Bouts of moderate to vigorous intensity physical activity lasting longer than 3 min, 5 min and 10 min.
**Significantly different compared with 4 sec (**p < 0.01). †, ‡Significantly different compared with 20 sec (†p < 0.05, ‡p < 0.01).
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affects the estimation of the PA bouts under free-living
conditions in middle-aged to older adults. The 20- and 60-
second epoch lengths resulted in larger amounts of MVPA
bouts compared with the 4-second epoch length. Thus,
caution should be exercised regarding the accelerometer’s
data setting when discussing the PA bouts reported in pre-
vious publications. Furthermore, the best epoch length to
estimate MVPA bouts remains unclear.
One of the original findings of the present investigation
is that, with regard to the accelerometer-based PA assess-
ment, a shorter epoch length results in smaller amounts
of PA bouts compared with the longer epoch lengths
under free-living conditions in middle aged to older
adults. Although several previous investigations have
examined the effects of an accelerometer’s epoch length
on the estimation of sporadic MVPA [6,8,20], the present
investigation provides the first demonstration that an
accelerometer’s epoch length affects the estimation of the
frequency and time of PA bouts. A previous study showed
that a shorter epoch length was more suitable for estimat-
ing the time spent in sporadic MVPA, where MVPA were
significantly higher and light-intensity activity was signifi-
cantly lower when presented as 10 sec epochs compared
with that using a 60 sec epoch length [8]. Similar results
are also found in adolescents and children where a signifi-
cant epoch effect was seen for time spent in VPA, LPA,
and rest in the child and adolescent samples and MVPA
in the child sample [10]. These findings are consistent
with the results of the present investigation, where the
daily time spent in sporadic MPA and VPA based on the
shortest epoch length (4 sec) were significantly longer than
that based on the longer epoch lengths (Table 2). However,with regard to the PA bouts, it is of interest that the rela-
tionships between the accelerometer’s epoch length and
the amount of PA were inverted (Table 3). The frequency
and time for the PA bouts were significantly smaller for
the shorter epoch length setting compared with the longer
epoch length settings. The mean daily time for MVPA10
under the shortest epoch length setting was less than half
of that under the longer epoch length settings.
The main explanation for the differences in the amount
of PA among the three different epoch lengths is consid-
ered to be due to two different factors. First, the bout dur-
ation of daily PA is very short under free-living conditions
[12,16,17]. Orendurff et al. previously indicated that 60%
of all walking bouts lasted less than 30 seconds, and 81%
of all walking bouts lasted 1 minute or less, and 2 minute
walking bouts represented just 1% of all walking bouts
[12]. Second, the shorter epoch has a higher sensitivity to
detect the changes in the human PA, such as the transi-
tion to PA from rest, and/or the switch from walking to
jogging, etc., compared with the longer epoch length.
Under the 1 min epoch length, for example, if people walk
for five seconds then rest for 55 seconds, this 1 min would
be categorized as LPA or MVPA rather than a resting
period. Similarly, if people take a short break during con-
tinuous jogging, this minute would be categorized as MPA
rather than VPA, regardless of the presence or absence of
the break. In other words, with regard to the 60 sec epoch
length, the intensity of PA is less likely to result in a classi-
fication of inactivity or VPA, because the various types of
PA, including the inactivity, are averaged over 1 min peri-
ods. As a result, the accelerometer might detect a larger
number of PA bouts. In contrast, a shorter epoch length
can more sensitively detect the changes in the type and
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ruptions, etc.). Thereafter, the PA bouts were significantly
smaller for the shorter epoch length compared with the
longer epoch length.
There is large variability in MVPA bouts lasting longer
than 10 minutes. In the present investigation, the mean
MVPA lasting > 10 minutes was 2.6 ± 5.4 min day-1 under
the 4-second epoch length. Similarly, the time for MVPA
bouts was 2.0 min day in the US NHANES Study [21], 0.4
to 0.6 min day-1 in British, Italian and French volunteers
[22] and 0.0 to 5.2 min day-1 in a Japanese study [23]. In
contrast, some investigators have reported much longer
MVPA bouts of > 30 min day-1 in overweight and obese
individuals [24], 19.2 ± 18.6 min day-1 in overweight parti-
cipants and 25.8 ± 23.4 min day-1 in normal-weight indivi-
duals [5]. The differences in the amounts of MVPA bouts
seem to exceed the acceptable range and are caused not
only by the epoch length, including human-behavioral ele-
ments, but also by the data analysis process. In other
words, the procedures used to assess and quantify the PA
bouts must evolve in order to determine how to manage
brief interruptions (i.e. breaks of < 1 minute) of PA. In the
present investigation, all MVPA bouts satisfied the inclu-
sion criteria, where the intensity of PA was above 3 METs
for that lasting at least 10 minutes. In contrast, some
investigators have attempted to improve the sensitivity of
detecting MVPA bouts. For example, to allow for the brief
periods of rest common during certain activities, i.e. paus-
ing for a water break while playing basketball, the criteria
used to define a bout requires a running average of 70% of
the counts to be above the cut-off point [21]. Similarly,
interruptions of 1 or 2 minutes below 3 METs are allowed
during consecutive MVPA lasting > 10 minutes to define
bouts of MVPA [25]. We cannot conclusively define the
best epoch length to estimate PA bouts because we were
unable to compare the accelerometer’s outputs with the
“gold standard method for assessing PA bouts.” Because it
is difficult to assess the bout duration of PA under free-
living conditions, using video tape recordings and/or dir-
ect observation is the gold standard method for assessing
PA bouts in experimental studies.
However, the previous and present investigations appar-
ently indicate that a shorter epoch length may be superior
to estimate the PA bouts compared to a longer epoch
length [8,26]. Furthermore, recent publications showed
that, although PA bouts are relatively rare under free-
living conditions, the MVPA lasting > 1 min was signifi-
cantly associated with the blood lipid status and age in
previous studies [16,17]. In contrast, with regard to the
1 min epoch length, it is doubtful whether it can evaluate
“real” PA bouts under free-living conditions, due to the
lack of accurate treatment of the interruptions in activity.
Further investigations will be required to determine how
to divide the continuous PA with interruptions and theintermittent PA, how to assess the activity level during
these short interruptions, and what length of interruptions
can be accepted, etc. However, a recent publication, which
summarized accelerometer-based research, showed that
the longer epoch duration (1 minute) is the most com-
monly used epoch length [6]. In addition, the time for
MVPA bouts lasting > 10 minutes based on the 60-second
epoch length is also significantly associated with health
outcomes using this length [4,5]. Additionally, using a
longer epoch length can reduce the data to be saved, so
the results using a longer epoch length would be superior
with regard to data treatment, and would allow for a
longer monitoring period by saving the data storage cap-
acity. Therefore, each epoch length has both advantages
and disadvantages. Future research should first develop a
method to quantify the PA bouts on the basis of a detailed
analysis, thereafter, the contribution of the different PA
bouts to the health outcomes should be examined based
on the quantitative assessment of the PA bouts based on
the most valid epoch length.
There are several limitations to the present investigation
that should be considered when interpreting the results.
First, the type (uni-axial) and position (waist) of the accel-
erometer used in the present investigation does not allow
for the collection of upper body activity, and thus may
underestimate the total PA. Additionally, as the LC has an
original algorithm for PA intensity classification, the results
of the present investigation should be confirmed using
other activity monitors. Second, the participants evaluated
in the present investigation were primarily middle-aged,
non-active males and females. Furthermore, the partici-
pants all lived in urban areas, and buses and trains were
their primary means of transportation. Thus, it is limited to
generalize the present investigation to the heterogeneous
individuals, therefore, the results of the present investiga-
tion should be confirmed in active individuals and hetero-
geneous volunteers, including young children.
Conclusion
In summary, the present investigation was the first to
examine the role of the accelerometer’s epoch length on
the evaluation of the PA bouts with regard to the
accelerometer-based PA assessment. The frequency and
time for the PA bouts were significantly lower as the
epoch length increased. These results indicate that the
accelerometer’s epoch length affects the estimation of the
PA bouts under free-living conditions in middle-aged to
older adults. Thus, caution should be exercised when
selecting the accelerometer’s data setting, and when dis-
cussing the results of previous studies about the PA bouts.
The best epoch length to estimate MVPA bouts remains
unclear, and will need to be assessed in future studies. In
order to generalize the results of the present investigation,
future studies should examine the effects of the epoch
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